FTH1P3 promotes the paclitaxel resistance in human breast cancer tumorigenesis by targeting miR‐206/ABCB1 axis, suggesting the novel molecular mechanism of breast cancer chemotherapy resistance. The gene discussed is FTH1P3; the disease is breast carcinoma.